相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiotoxicity profile of trastuzumab
Steven M. Ewer et al.
DRUG SAFETY (2008)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Which one is better: AIDS related or HIV associated?
Hueseyin Abali et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment
MS Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer
YL Tham et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
